VanEck Pharmaceutical ETF (NASDAQ:PPH) Stake Lessened by Nadler Financial Group Inc.

Nadler Financial Group Inc. lowered its holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 9.0% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,725 shares of the company’s stock after selling 270 shares during the period. Nadler Financial Group Inc.’s holdings in VanEck Pharmaceutical ETF were worth $249,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Independent Advisor Alliance increased its stake in shares of VanEck Pharmaceutical ETF by 100.8% in the fourth quarter. Independent Advisor Alliance now owns 98,473 shares of the company’s stock worth $7,939,000 after acquiring an additional 49,423 shares during the last quarter. Financial Partners Group Inc acquired a new position in shares of VanEck Pharmaceutical ETF in the second quarter worth $8,701,000. J.Safra Asset Management Corp increased its position in VanEck Pharmaceutical ETF by 5.9% during the second quarter. J.Safra Asset Management Corp now owns 73,609 shares of the company’s stock worth $6,734,000 after buying an additional 4,084 shares during the last quarter. Avestar Capital LLC acquired a new position in VanEck Pharmaceutical ETF during the fourth quarter worth $4,284,000. Finally, Gladstone Institutional Advisory LLC acquired a new position in VanEck Pharmaceutical ETF during the fourth quarter worth $3,818,000.

VanEck Pharmaceutical ETF Trading Up 0.6 %

VanEck Pharmaceutical ETF stock traded up $0.58 during mid-day trading on Tuesday, hitting $97.34. 65,533 shares of the company’s stock were exchanged, compared to its average volume of 137,311. The stock has a market cap of $656.07 million, a P/E ratio of 21.04 and a beta of 0.72. VanEck Pharmaceutical ETF has a 1-year low of $74.05 and a 1-year high of $97.61. The stock has a 50 day moving average of $92.85 and a two-hundred day moving average of $90.30.

VanEck Pharmaceutical ETF Cuts Dividend

The firm also recently announced a dividend, which was paid on Friday, July 5th. Shareholders of record on Monday, July 1st were given a dividend of $0.3558 per share. The ex-dividend date was Monday, July 1st.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.